Page last updated: 2024-09-04

cd 437 and cytarabine

cd 437 has been researched along with cytarabine in 1 studies

Compound Research Comparison

Studies
(cd 437)
Trials
(cd 437)
Recent Studies (post-2010)
(cd 437)
Studies
(cytarabine)
Trials
(cytarabine)
Recent Studies (post-2010) (cytarabine)
13402615,4872,4243,188

Protein Interaction Comparison

ProteinTaxonomycd 437 (IC50)cytarabine (IC50)
nuclear receptor coactivator 3 isoform aHomo sapiens (human)7.533
E3 ubiquitin-protein ligase Mdm2Homo sapiens (human)0.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhalla, K; Dawson, MI; Fontana, JA; Han, Z; Ordónez, JV; Poirer, G; Reichert, U; Rishi, AK; Sheikh, MS; Shroot, B; Sun, RJ; Tschang, SH; Wyche, J; Zhang, Y1

Other Studies

1 other study(ies) available for cd 437 and cytarabine

ArticleYear
Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid.
    Oncology research, 1998, Volume: 10, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Caspase 3; Caspases; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cytarabine; Cytochrome c Group; Enzyme Activation; HL-60 Cells; Humans; Mitochondria; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Retinoids; RNA, Messenger; Up-Regulation

1998
chemdatabank.com